David A. Jacobsohn

18.2k total citations · 2 hit papers
126 papers, 4.0k citations indexed

About

David A. Jacobsohn is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David A. Jacobsohn has authored 126 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Hematology, 38 papers in Public Health, Environmental and Occupational Health and 27 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David A. Jacobsohn's work include Hematopoietic Stem Cell Transplantation (88 papers), Acute Lymphoblastic Leukemia research (35 papers) and Childhood Cancer Survivors' Quality of Life (22 papers). David A. Jacobsohn is often cited by papers focused on Hematopoietic Stem Cell Transplantation (88 papers), Acute Lymphoblastic Leukemia research (35 papers) and Childhood Cancer Survivors' Quality of Life (22 papers). David A. Jacobsohn collaborates with scholars based in United States, Canada and United Kingdom. David A. Jacobsohn's co-authors include Georgia B. Vogelsang, Morris Kletzel, Reggie Duerst, Joseph Pidala, Madan Jagasia, Steven Z. Pavletic, Stephanie J. Lee, Jeanne Palmer, Navneet S. Majhail and Xiaoyu Chai and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

David A. Jacobsohn

122 papers receiving 4.0k citations

Hit Papers

Long-Term Survival and Late Deaths After Allogeneic Hemat... 2011 2026 2016 2021 2011 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
    2011 443 citations Navneet S. Majhail, Ruta Brazauskas et al. profile →
  2. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
    2015 280 citations Stephanie J. Lee, Yoshihiro Inamoto et al. Biology of Blood and Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Jacobsohn United States 34 2.8k 962 834 788 713 126 4.0k
Hélène Espérou France 36 2.9k 1.0× 1.0k 1.1× 1.1k 1.3× 925 1.2× 843 1.2× 90 4.6k
Yoshihiro Inamoto Japan 35 2.8k 1.0× 1.1k 1.2× 573 0.7× 887 1.1× 847 1.2× 172 3.9k
Carlo Dufour Italy 38 2.9k 1.0× 1.2k 1.3× 871 1.0× 674 0.9× 1.2k 1.7× 174 5.1k
Helen Baldomero Switzerland 38 3.3k 1.2× 925 1.0× 816 1.0× 1.1k 1.3× 1.3k 1.8× 96 4.6k
Masahiro Tsuchida Japan 34 2.9k 1.0× 944 1.0× 527 0.6× 1.2k 1.5× 963 1.4× 160 4.3k
Satoshi Takahashi Japan 36 3.3k 1.2× 892 0.9× 742 0.9× 949 1.2× 1.1k 1.6× 273 4.4k
Giovanna Giorgiani Italy 33 2.0k 0.7× 908 0.9× 629 0.8× 544 0.7× 575 0.8× 93 2.9k
Cindy Ippoliti United States 31 2.9k 1.0× 1.3k 1.3× 608 0.7× 719 0.9× 1.2k 1.7× 81 4.4k
Chiara Messina Italy 37 2.1k 0.8× 691 0.7× 355 0.4× 1.1k 1.4× 847 1.2× 134 3.6k
Jeanne Palmer United States 30 2.0k 0.7× 559 0.6× 695 0.8× 561 0.7× 605 0.8× 153 2.9k

Countries citing papers authored by David A. Jacobsohn

Since Specialization
Citations

This map shows the geographic impact of David A. Jacobsohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Jacobsohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Jacobsohn more than expected).

Fields of papers citing papers by David A. Jacobsohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Jacobsohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Jacobsohn. The network helps show where David A. Jacobsohn may publish in the future.

Co-authorship network of co-authors of David A. Jacobsohn

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Jacobsohn. A scholar is included among the top collaborators of David A. Jacobsohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Jacobsohn. David A. Jacobsohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobsohn, David A., et al.. (2025). Advances in Gene Therapy for Sickle Cell Disease: From Preclinical Innovations to Clinical Implementation and Access Challenges. The CRISPR Journal. 8(3). 174–188. 2 indexed citations
2.
Shah, Niketa C., Allistair Abraham, Eric Anderson, et al.. (2025). Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplantation and Cellular Therapy. 31(10). 826.e1–826.e10. 1 indexed citations
3.
Dvorak, Christopher C., Janel Long-Boyle, Hisham Abdel‐Azim, et al.. (2024). Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19–depleted pediatric haploidentical HCT for hematologic malignancy. Blood Advances. 8(23). 6003–6014. 3 indexed citations
4.
Abraham, Allistair, Michael D. Keller, Carolina Colli Cruz, et al.. (2019). Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Advances. 3(14). 2057–2068. 33 indexed citations
5.
Thakar, Monica S., Larisa Broglie, Brent R. Logan, et al.. (2018). The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood. 133(7). 754–762. 35 indexed citations
6.
Schechter, Tal, Evelio Perez‐Albuerne, Tiffany Lin, et al.. (2018). Veno-occlusive disease after high-dose busulfan–melphalan in neuroblastoma. Bone Marrow Transplantation. 55(3). 531–537. 19 indexed citations
7.
Duncan, Christine, Ruta Brazauskas, Jiaxing Huang, et al.. (2018). Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 53(10). 1278–1287. 27 indexed citations
8.
Hanisch, Benjamin, David A. Jacobsohn, & Roberta L. DeBiasi. (2016). Diagnosis and Management of Pediatric Transplant-associated Viral Infections. The Pediatric Infectious Disease Journal. 35(4). 449–451. 2 indexed citations
9.
MacMillan, Margaret L., Marie Robin, Andrew C. Harris, et al.. (2015). A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality. Biology of Blood and Marrow Transplantation. 21(4). 761–767. 161 indexed citations
10.
Grimley, Michael, Gabriela Marón, Vinod K. Prasad, et al.. (2015). Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection. Biology of Blood and Marrow Transplantation. 21(2). S108–S109. 7 indexed citations
11.
Inamoto, Yoshihiro, Madan Jagasia, William A. Wood, et al.. (2014). Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD. Bone Marrow Transplantation. 49(4). 532–538. 15 indexed citations
12.
Palmer, Jeanne, Stephanie J. Lee, Xiaoyu Chai, et al.. (2012). Poor Agreement between Clinician Response Ratings and Calculated Response Measures in Patients with Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 18(11). 1649–1655. 21 indexed citations
13.
Jacobsohn, David A.. (2010). Optimal management of chronic graft‐versus‐host disease in children. British Journal of Haematology. 150(3). 278–292. 18 indexed citations
14.
McNeer, Jennifer L., et al.. (2009). Early Elevation of C-Reactive Protein Correlates with Severe Infection and Nonrelapse Mortality in Children Undergoing Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(3). 350–357. 24 indexed citations
15.
Burke, Michael J., David Walterhouse, David A. Jacobsohn, Reggie Duerst, & Morris Kletzel. (2007). Tandem high‐dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high‐risk Ewing family tumors. Pediatric Blood & Cancer. 49(2). 196–198. 21 indexed citations
16.
17.
Browning, Brittan, et al.. (2005). Weight loss in pediatric patients with chronic graft-versus-host disease (cGVHD). Biology of Blood and Marrow Transplantation. 11(2). 71–71.
18.
Jacobsohn, David A., et al.. (2005). Favorable Outcome for Infant Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 11(12). 999–1005. 18 indexed citations
19.
20.
Goldberg, Jenna D., David A. Jacobsohn, Jeffrey Margolis, et al.. (2003). Pentostatin for the Treatment of Chronic Graft-Versus-Host Disease in Children. Journal of Pediatric Hematology/Oncology. 25(7). 584–588. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Espérou Breakdown of academic impact, for papers by Yoshihiro Inamoto Breakdown of academic impact, for papers by Carlo Dufour Breakdown of academic impact, for papers by Helen Baldomero Breakdown of academic impact, for papers by Masahiro Tsuchida Breakdown of academic impact, for papers by Satoshi Takahashi Breakdown of academic impact, for papers by Giovanna Giorgiani Breakdown of academic impact, for papers by Cindy Ippoliti Breakdown of academic impact, for papers by Chiara Messina Breakdown of academic impact, for papers by Jeanne Palmer
Rankless by CCL
2026